The first Phase III trials -- named 4Humanity trials -- of an inactivated vaccine for COVID-19 in the United Arab Emirates are among the largest in the world in volunteer recruitment having reached 31,000 vaccinated volunteers from more than 120 nationalities in only six weeks, reported the Emirates News Agency (WAM) on Sunday.
The trials are being managed by Abu-Dhabi based G42 Healthcare in partnership with the Department of Health - Abu Dhabi, the UAE Ministry of Health and Prevention (MoHaP) and Abu Dhabi Health Services Company.
For more coronavirus news, visit our dedicated page.
The speed and efficiency of volunteer registration, screening and vaccination is setting new global benchmarks for the 4Humanity trials of the inactivated vaccine developed by Sinopharm CNBG, a world-leading Chinese vaccine manufacturer.
The Department of Health, Abu Dhabi, has confirmed that there are now sufficient numbers of volunteers required to complete the clinical trial so no new registrations will be accepted effective from Sunday (August 30).